ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CTEC Convatec Group Plc

261.80
0.60 (0.23%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Convatec Group Plc LSE:CTEC London Ordinary Share GB00BD3VFW73 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.60 0.23% 261.80 262.40 262.80 263.40 260.20 261.60 4,659,327 16:35:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 2.14B 130.3M 0.0636 41.29 5.38B

ConvaTec Group PLC Director/PDMR Shareholding (1037M)

19/05/2022 10:00am

UK Regulatory


Convatec (LSE:CTEC)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Convatec Charts.

TIDMCTEC

RNS Number : 1037M

ConvaTec Group PLC

19 May 2022

19 May 2022

ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 18 May 2022, Jonny Mason, Chief Financial Officer and PDMR, purchased 22,000 Shares of 10 pence in the Company. Jonny Mason's resulting shareholding is 22,000 Shares.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
  1       Details of the person discharging managerial responsibilities/person 
           closely associated 
  a)     Name                                             Jonny Mason 
  2      Reason for the notification 
  a)     Position/Status                                  Chief Financial Officer 
  b)     Initial notification/Amendment                   Initial notification 
  3      Details of the issuer, emission allowance market participant, 
          auction platform, auctioneer or auction monitor 
  a)     Name                                             ConvaTec Group Plc 
  b)     LEI                                              213800LS272L4FIDOH92 
  4      Details of the transaction(s): section to be repeated for 
          (i) each type of instrument; (ii) each type of transaction; 
          (iii) each date; and (iv) each place where transactions have 
          been conducted 
  a)     Description of the financial                     Ordinary share of 10p each in ConvaTec Group Plc 
          instrument, type of instrument 
          Identification code                              GB00BD3VFW73 
  b)     Nature of the transaction                         Purchase of Ordinary shares of 10p each in ConvaTec Group 
                                                           Plc 
   c)     Price(s) and volume(s)                          Price(s)                                         Volume(s) 
                                                           GBP2.238                                         22,000 
  d)     Aggregated information 
          - Aggregated volume                               n/a 
          - Price                                           n/a 
  e)     Date of the transaction                          2022-05-18 
  f)     Place of the transaction                         London Stock Exchange, Main Market (XLON) 
 
 

Enquiries

Analysts and Investors

   Kate Postans, VP Investor Relations, ConvaTec                   +44 (0)782 644 7807 

ir@convatec.com

Media

   Buchanan: Charles Ryland / Chris Lane                                   +44 (0)207 466 5000 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFIFSTEIIALIF

(END) Dow Jones Newswires

May 19, 2022 05:00 ET (09:00 GMT)

1 Year Convatec Chart

1 Year Convatec Chart

1 Month Convatec Chart

1 Month Convatec Chart

Your Recent History

Delayed Upgrade Clock